Dance therapy shows promise for breast cancer patients
NCT ID NCT07553702
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a 12-week dance program can reduce pain, fatigue, and improve quality of life in women being treated for breast cancer. Twenty-eight women will either take dance classes twice a week or continue their normal routine. Researchers will measure changes in pain, fatigue, balance, and emotional well-being.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- dance program
- What this could lead to
- If it works, this could offer a fun, drug-free way to help women feel better physically and emotionally during breast cancer treatment.
- What could go wrong
- This is a small, early-stage study with only 28 participants, so results may not apply to everyone. The benefits of dance are not yet proven and may be modest.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 28 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Apr 2025
- Expected to finish
-
Aug 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Women aged 18 years or older; * Diagnosed with breast cancer; * Undergoing adjuvant breast cancer treatment (chemotherapy, radiotherapy, immunotherapy, and/or hormone therapy); * Women at least 3 months post-surgery. Exclusion Criteria: * To have another type of cancer; * To have a cognitive impairment or injury that prevents the ability to complete physical assessments or fill out questionnaires.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast - female are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Federal University of Maranhao
São Luís, Maranhão, Brazil
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common steroid shield breast cancer patients from a dangerous drug side effect?
- Tiny magnetic seeds could guide surgeons to the right lymph node
- New PET tracer aims to light up hidden cancer targets
- Gut bacteria supplement tested against chemo hair loss
- Can a mindfulness program boost Self-Compassion in breast cancer survivors?
- Can a Decades-Old Anti-Inflammatory drug quiet the joint pain that drives women off breast cancer therapy?